Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-09 Purchase |
2025-04-11 5:29 pm |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
149,075 | $10.21 | $1,522,517 | 9,630,893 (Indirect Direct) |
View |
| 2025-03-18 Purchase |
2025-03-20 7:50 pm |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
89,863 | $15.26 | $1,371,154 | 9,481,818 (Indirect Direct) |
View |
| 2025-01-13 Purchase |
2025-01-15 4:08 pm |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
20,967 | $17.47 | $366,354 | 9,391,955 (Indirect Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 8:05 pm |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
4,875 | $16.78 | $81,790 | 62,258 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 8:05 pm |
Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer |
1,880 | $16.78 | $31,542 | 35,393 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 8:05 pm |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
2,550 | $16.78 | $42,783 | 53,490 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 8:05 pm |
Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer |
1,797 | $16.78 | $30,149 | 40,226 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 8:04 pm |
Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO |
17,271 | $16.78 | $289,764 | 204,096 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 8:04 pm |
Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer |
7,989 | $16.78 | $134,036 | 94,811 (Direct) |
View |
| 2024-12-19 Purchase |
2024-12-23 5:20 pm |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
52,189 | $18.49 | $965,021 | 9,368,388 (Indirect Direct) |
View |
| 2024-12-09 Sale |
2024-12-11 4:28 pm |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
13,664 | $25.26 | $345,134 | 212,132 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-21 6:52 pm |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
38,689 | $16.78 | $649,030 | 400,600 (Direct) |
View |
| 2024-11-14 Purchase |
2024-11-18 7:35 pm |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
431,940 | $17.07 | $7,373,527 | 9,316,199 (Indirect Direct) |
View |
| 2024-11-14 Sale |
2024-11-18 7:32 pm |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
82,368 | $17.46 | $1,438,038 | 536,257 (Direct) |
View |
| 2024-11-14 Sale |
2024-11-18 7:28 pm |
Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer |
55,000 | $16.5 | $907,533 | 99,329 (Direct) |
View |
| 2024-11-14 Sale |
2024-11-18 7:23 pm |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
52,115 | $16.79 | $875,042 | 222,869 (Direct) |
View |
| 2024-10-02 Purchase |
2024-10-04 5:58 pm |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
205,721 | $20.87 | $4,293,545 | 12,759,887 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-15 Exercise |
2025-04-16 4:35 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer |
7,500 | $3.3 | 89,595 (Direct) |
View |
| 2025-04-15 Exercise |
2025-04-16 4:35 pm |
N/A 2031-04-25 |
Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer |
7,500 | $0 | 89,595 (Direct) |
View |
| 2025-01-10 Exercise |
2025-01-13 4:09 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
9,000 | $3.23 | 129,922 (Direct) |
View |
| 2025-01-10 Exercise |
2025-01-13 4:09 pm |
N/A 2033-01-15 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
9,000 | $0 | 129,922 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:21 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO |
226,600 | $0 | 589,500 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:21 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
63,500 | $0 | 103,440 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:21 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer |
63,500 | $0 | 89,423 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:20 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer |
86,600 | $0 | 271,066 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:20 pm |
2026-01-02 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | ZENNER PATRICK J Director |
10,400 | $0 | 25,774 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:20 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer |
75,000 | $0 | 93,273 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:20 pm |
2026-01-02 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Kalayoglu Murat Director 10% Owner |
10,400 | $0 | 5,072,037 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:20 pm |
2026-01-02 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | BARABE TIMOTHY C Director |
10,400 | $0 | 32,166 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:19 pm |
2026-01-02 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
10,400 | $0 | 9,378,788 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:19 pm |
2026-01-02 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Malik Kemal Director |
10,400 | $0 | 16,333 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:19 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
63,500 | $0 | 114,533 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:19 pm |
2026-01-02 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Singer Michael Director |
10,400 | $0 | 736,201 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:19 pm |
2026-01-02 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | COX CARRIE SMITH Director |
10,600 | $0 | 31,895 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 4:19 pm |
2026-01-02 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | DeSilva Nishan M Director |
10,400 | $0 | 24,166 (Direct) |
View |
| 2024-12-26 Gift |
2024-12-30 4:14 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Singer Michael Director |
20,000 | $0 | 725,801 (Direct) |
View |
| 2024-12-26 Exercise |
2024-12-30 4:11 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | English Emily SVP, Head of Manufacturing |
7,650 | $3.3 | 75,292 (Direct) |
View |
| 2024-12-26 Exercise |
2024-12-30 4:11 pm |
N/A 2031-04-25 |
Cartesian Therapeutics Inc. | RNAC | English Emily SVP, Head of Manufacturing |
7,650 | $0 | 75,292 (Direct) |
View |
| 2024-12-09 Exercise |
2024-12-11 4:28 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
13,664 | $1.41 | 212,132 (Direct) |
View |
| 2024-12-09 Exercise |
2024-12-11 4:28 pm |
N/A 2026-11-06 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
13,664 | $0 | 212,132 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-21 6:52 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
38,689 | $1.41 | 400,600 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-21 6:52 pm |
N/A 2026-11-06 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
38,689 | $0 | 400,600 (Direct) |
View |
| 2024-11-19 Gift |
2024-11-21 6:51 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Singer Michael Director |
28,821 | $0 | 745,801 (Direct) |
View |
| 2024-11-20 Exercise |
2024-11-21 6:50 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
14,000 | $3.23 | 116,372 (Direct) |
View |
| 2024-11-20 Exercise |
2024-11-21 6:50 pm |
N/A 2033-01-15 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
14,000 | $0 | 116,372 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:32 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
82,368 | $1.41 | 536,257 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:32 pm |
N/A 2026-11-06 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
82,368 | $0 | 536,257 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:28 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer |
55,000 | $3.23 | 99,329 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:28 pm |
N/A 2031-09-12 |
Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer |
55,000 | $0 | 99,329 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:23 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
52,115 | $3.23 | 222,869 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:23 pm |
N/A 2033-01-15 |
Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer |
52,115 | $0 | 222,869 (Direct) |
View |
| 2024-10-11 Exercise |
2024-10-15 4:53 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Kalayoglu Murat Director 10% Owner |
1,563,924 | $0 | 5,118,039 (Indirect) |
View |
| 2024-10-11 Exercise |
2024-10-15 4:43 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Hoge Elizabeth Seven One Eight Three Four Irrevocable Trust 10% Owner |
1,563,924 | $0 | 5,118,039 (Indirect) |
View |
| 2024-10-02 Other |
2024-10-04 5:58 pm |
2022-04-11 2027-04-11 |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
4,505,650 | $0 | 12,759,887 (Indirect) |
View |
| 2024-09-25 Exercise |
2024-09-27 4:13 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner |
2,359,500 | $0 | 6,029,547 (Direct) |
View |